Document is current
Any future updates will be listed below
-
Authors
Romijnders, Kim A. G. J. https://orcid.org/0000-0002-1491-3826
Romero Gonzalez, Franco https://orcid.org/0009-0008-4509-8060
Matser, Amy
Verburgh, Myrthe L.
Dijkstra, Maartje
Reiss, Peter https://orcid.org/0000-0001-7896-6428
Kretzschmar, Mirjam https://orcid.org/0000-0002-4394-7697
Nieuwkerk, Pythia
Schim van der Loeff, Maarten https://orcid.org/0000-0002-4903-7002
Basten, Maartje https://orcid.org/0000-0001-9982-7048
Rozhnova, Ganna https://orcid.org/0000-0002-6725-7359
-
Funding
Funding for this research was provided by:
Aids Fonds (P-52901, P-52901)
- License Information
-
More Information
Article History
Received: 23 April 2024
Accepted: 7 April 2025
First Online: 3 May 2025
Competing interests
: The authors declare competing interests for: The institution of M. F. Schim van der Loeff received study funding from GSK; he served on advisory boards of GSK and Merck. P.R. has received grant support from Gilead Sciences, ViiV Healthcare, and Merck & Co. G.R. is an Editorial Board Member of Communications Medicine , but was not involved in the editorial review or peer review, nor the decision to publish this article. The other authors have no competing interests to disclose.
